Perakizumab, a emerging drug the company, presents a important breakthrough in the treatment against multiple scarring diseases. Unlike existing therapies, this agent selectively targets blocks TGF-beta signaling, a https://dirstop.com/story28461090/perakizumab-a-promising-treatment-for-scarring-illness